CASP2 and metabolic dysfunction-associated steatotic liver disease: Further, caspase-2 is required for the progression from non-alcoholic fatty liver disease to non-alcoholic steatohepatitis, which is considered a risk factor for further liver damage that promotes hepatocellular carcinoma (Kim et al., 2018).